Events & Presentations

4 stars based on 75 reviews

The selection of PCG Advisory Group reflects our desire to further support our goals by strategically presenting our corporate and investor message to a wide audience of U. As we continue to add depth to our product pipeline as well as strategic collaborations, now option investor relations the time to ensure the Zomedica investment case is heard throughout the investment community.

With positive growth potential coinciding with a U. Zomedica may terminate the agreement at any time after February 14, upon the provision of 30 days written notice. Zomedica also announces that, pursuant to its stock option plan, it has granted stock options to acquire up to an option investor relations of 1, Common Shares, of which, 1, stock options were granted to certain officers of Zomedica.

The foregoing option investor relations options all vested immediately upon the date of grant. All of the stock options announced herein including those granted to PCG Advisory Groupand any Common Shares issued upon exercise of the stock options, are subject to standard hold period restrictions, including a four-month hold period under Canadian securities laws expiring on December 15, About Zomedica With U. Zomedica is developing a diversified portfolio to include diagnostics, devices, innovative drugs, and drug-delivery technologies.

For more information, visit www. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations option investor relations prove to be correct. We cannot guarantee future results, performance or achievements.

Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated option investor relations the forward-looking information.

Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: Readers are cautioned that this list of risk factors should not be construed as exhaustive.

The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in option investor relations expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information. Media Contact Andrea Eberle aeberle zomedica.

Sec regulation alternative trading system

  • Nicht funktionieren opzionibinarie

    Trade without broker

  • Interactive optioncom

    Global option 5 minute binary options trading indicators

Binary options regulated and scam brokers forex peace army your forex trading forum

  • Category binary option robot download

    Nybot sugar options broker

  • Binary options trading using pivot points

    Nx trading options the rush of binary options trading

  • Vault option binary trading demo account without deposit

    Comercio de opciones no cubiertas

Robot binario de superusuario apk

21 comments 250 in binary trading trading vs

Trevor options trader

ZOM "Zomedica" , a veterinary pharmaceutical and health care solutions company, today announced that it has retained PCG Advisory Group, a leading integrated communications firm, to serve as an advisor for investor relations and social media communications strategies. The selection of PCG Advisory Group reflects our desire to further support our goals by strategically presenting our corporate and investor message to a wide audience of U. As we continue to add depth to our product pipeline as well as strategic collaborations, now is the time to ensure the Zomedica investment case is heard throughout the investment community.

With positive growth potential coinciding with a U. Zomedica may terminate the agreement at any time after February 14, upon the provision of 30 days written notice. Such options vest quarterly over a period of one year and shall be subject to regulatory approval and the provisions of Zomedica's Stock Option Plan. Zomedica also announces that, pursuant to its stock option plan, it has granted stock options to acquire up to an aggregate of 1,, Common Shares, of which, 1,, stock options were granted to certain officers of Zomedica.

The foregoing stock options all vested immediately upon the date of grant. All of the stock options announced herein including those granted to PCG Advisory Group , and any Common Shares issued upon exercise of the stock options, are subject to standard hold period restrictions, including a four-month hold period under Canadian securities laws expiring on December 15, About Zomedica With U.

Zomedica is developing a diversified portfolio to include diagnostics, devices, innovative drugs, and drug-delivery technologies. For more information, visit www. Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur.

Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements.

Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information.

Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: Readers are cautioned that this list of risk factors should not be construed as exhaustive. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation.

Readers are cautioned not to place undue reliance on forward-looking information. More articles related to: Company Announcement Profile Zomedica. August 14, With a Reader Account, it's easy to send email directly to the contact for this release.

Sign up today for your free Reader Account! Already have an account? GlobeNewswire , a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.